Cenyx Biotech Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Cenyx Biotech Inc. - overview
Established
2016
Location
Seoul, -, South Korea
Primary Industry
Biotechnology
About
Based in Seoul, South Korea, and founded in 2016, Cenyx Biotech Inc. operates as a nano-medicine company engaged in the development of a nano-biotech agent. In April 2026, Cenyx Biotech Inc. raised KRW 12.
5 billion in venture funding from new investor Scale Up Partners. Returning investors SBI Investment, Partners Investment, AJU IB Investment, CKD Venture Capital, SL Investment, InterValue Partners, and other unspecified investors also participated in this round. The company will use the April 2026 funding to accelerate global clinical trials for its CX213 pipeline and establish facilities for the production of its drug products.
Current Investors
AJU IB Investment, CKD Venture Capital, WONIK Investment Partners
Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.cenyxbiotech.com
Company Stage
Series B
Total Amount Raised
Subscriber access only
Cenyx Biotech Inc. - financials
| Fiscal Year Ended | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 |
|---|---|---|---|---|---|
| Revenue (USD) | - | 10,600,000 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - | - |
| EBITDA (USD) | - | - | - | - | - |
| Operating Income (USD) | (213,248,000) | (890,258,000) | - | - | - |
| Operating Margin | - | (8398.7%) | - | - | - |
| % EBITDA Margin | - | - | - | - | - |
| NET Income (USD) | (181,034,000) | (885,324,000) | - | - | - |
| % Net Margin | - | (8352.1%) | - | - | - |
Cenyx Biotech Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.